Artwork

Content provided by ResearchPod. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by ResearchPod or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ppacc.player.fm/legal.
Player FM - Podcast App
Go offline with the Player FM app!

RNA sequencing in Alzheimers investigations

27:04
 
Share
 

Manage episode 448789215 series 2680968
Content provided by ResearchPod. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by ResearchPod or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ppacc.player.fm/legal.

We humans share over 99% of our DNA with each other. This means personalised therapies for diseases such as cancer or neurodegenerative conditions have to be tailored to the most minute differences between us - or even between our own cells.

Professor Mark Ebbert of the Sanders-Brown Center on Aging at the University of Kentucky leads a lab focusing on isoforms of RNA - tiny, short lived molecules - that could open whole new avenues for detection, diagnosis, and treatments of otherwise incurable diseases.
Read the original research: https://doi.org/10.1101/2023.08.06.552162
Find more at The Ebbert Lab

  continue reading

472 episodes

Artwork
iconShare
 
Manage episode 448789215 series 2680968
Content provided by ResearchPod. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by ResearchPod or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ppacc.player.fm/legal.

We humans share over 99% of our DNA with each other. This means personalised therapies for diseases such as cancer or neurodegenerative conditions have to be tailored to the most minute differences between us - or even between our own cells.

Professor Mark Ebbert of the Sanders-Brown Center on Aging at the University of Kentucky leads a lab focusing on isoforms of RNA - tiny, short lived molecules - that could open whole new avenues for detection, diagnosis, and treatments of otherwise incurable diseases.
Read the original research: https://doi.org/10.1101/2023.08.06.552162
Find more at The Ebbert Lab

  continue reading

472 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Quick Reference Guide

Listen to this show while you explore
Play